Avi Products India Shuffles Leadership and Plans Office Move
Avi Products India Ltd announced significant leadership changes effective April 23, 2026. The company appointed multiple new directors and a new Chief Financial Officer. These appointments come as several existing directors and key managerial personnel have resigned.
Additionally, Avi Products India plans to move its registered office from Thane to Mumbai, a change that requires necessary approvals.
These extensive changes suggest a potential strategic shift under new leadership. Moving the registered office to Mumbai could signal better access to financial hubs or improved operations. Investors will closely watch how the new management team guides the company, especially its plans for expansion into Dental, Healthcare & Wellness Services.
The leadership transition follows an ownership shift earlier in April 2026, when promoter group member Vikram Avinash Vora sold his entire 5.82% stake. This exit and the subsequent board changes may indicate a broader 'change of control,' paving the way for a new strategic vision.
Avi Products India Ltd, formerly known as Avi Photochem Ltd, is involved in dental products and machinery, along with an ice cream franchise business. The company has also been exploring expansion into healthcare services.
Operationally, a completely new board and senior management team will now steer the company. Shareholder approval is required for the new director appointments, and regulatory clearances are needed for the office relocation from Thane to Mumbai. A recalibration of business strategy and operational focus is expected.
Financially, Avi Products India reported a net loss of ₹55.36 Lakhs for the quarter ended December 31, 2025, attributed to external economic factors. For the fiscal year 2024, the company recorded ₹5.05 Crores in revenue and a net profit of ₹25.49 Lakhs.
Investors will be looking for updates on the appointment of internal and secretarial auditors, the completion of shareholder approvals for new directors, and regulatory clearances for the office move. Initial policy announcements or strategic directives from the new leadership team will also be key.
